User profiles for FD Richard Hobbs
Richard HobbsHead of Primary Care Health Sciences, Oxford University Verified email at phc.ox.ac.uk Cited by 130366 |
[HTML][HTML] Global prevalence of chronic kidney disease–a systematic review and meta-analysis
…, JA Hirst, CA O'Callaghan, DS Lasserson, FDR Hobbs - PloS one, 2016 - journals.plos.org
Chronic kidney disease (CKD) is a global health burden with a high economic cost to health
systems and is an independent risk factor for cardiovascular disease (CVD). All stages of …
systems and is an independent risk factor for cardiovascular disease (CVD). All stages of …
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …
…, OH Franco, S Halvorsen, FDR Hobbs… - European journal of …, 2022 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …
…, OA Gbinigie, NM Rahman, G Hayward, DB Richards… - The Lancet, 2023 - thelancet.com
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study …
Background Anticoagulants are more effective than antiplatelet agents at reducing stroke
risk in patients with atrial fibrillation, but whether this benefit outweighs the increased risk of …
risk in patients with atrial fibrillation, but whether this benefit outweighs the increased risk of …
Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial …
…, P MacCallum, A Kakkar, FDR Hobbs… - Journal of clinical …, 2018 - ascopubs.org
Purpose Venous thromboembolism (VTE) is common in patients with cancer. Long-term daily
subcutaneous low molecular weight heparin has been standard treatment for such patients…
subcutaneous low molecular weight heparin has been standard treatment for such patients…
International clinical recommendations on scar management
…, RD Cooter, MH Gold, FDR Hobbs… - Plastic and …, 2002 - journals.lww.com
: Many techniques for management of hypertrophic scars and keloids have been proven
through extensive use, but few have been supported by prospective studies with adequate …
through extensive use, but few have been supported by prospective studies with adequate …
[HTML][HTML] Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
…, S De Lusignan, AB Docherty, D Ford, FDR Hobbs… - The Lancet, 2021 - thelancet.com
Background The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca)
COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical …
COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical …
[HTML][HTML] Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a …
Background There are few primary care studies of the COVID-19 pandemic. We aimed to
identify demographic and clinical risk factors for testing positive for severe acute respiratory …
identify demographic and clinical risk factors for testing positive for severe acute respiratory …
Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial
Background Control of blood pressure is a key component of cardiovascular disease
prevention, but is difficult to achieve and until recently has been the sole preserve of health …
prevention, but is difficult to achieve and until recently has been the sole preserve of health …
[HTML][HTML] Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label …
Background A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …